These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32317048)

  • 1. Loss of ARF/INK4A Promotes Liver Progenitor Cell Transformation Toward Tumorigenicity Supporting Their Role in Hepatocarcinogenesis.
    Strauss RP; Audsley KM; Passman AM; van Vuuren JH; Finch-Edmondson ML; Callus BA; Yeoh GC
    Gene Expr; 2020 Jun; 20(1):39-52. PubMed ID: 32317048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p16Ink4a or p19Arf loss contributes to Tal1-induced leukemogenesis in mice.
    Shank-Calvo JA; Draheim K; Bhasin M; Kelliher MA
    Oncogene; 2006 May; 25(21):3023-31. PubMed ID: 16407836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
    Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
    Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
    D'Amico M; Wu K; Di Vizio D; Reutens AT; Stahl M; Fu M; Albanese C; Russell RG; Muller WJ; White M; Negassa A; Lee HW; DePinho RA; Pestell RG
    Cancer Res; 2003 Jun; 63(12):3395-402. PubMed ID: 12810676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of p19(Arf) and p16(Ink4a) loss on senescence of murine bone marrow-derived preB cells and macrophages.
    Randle DH; Zindy F; Sherr CJ; Roussel MF
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9654-9. PubMed ID: 11481442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bmi1 promotes hepatic stem cell expansion and tumorigenicity in both Ink4a/Arf-dependent and -independent manners in mice.
    Chiba T; Seki A; Aoki R; Ichikawa H; Negishi M; Miyagi S; Oguro H; Saraya A; Kamiya A; Nakauchi H; Yokosuka O; Iwama A
    Hepatology; 2010 Sep; 52(3):1111-23. PubMed ID: 20648475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt.
    Uhrbom L; Dai C; Celestino JC; Rosenblum MK; Fuller GN; Holland EC
    Cancer Res; 2002 Oct; 62(19):5551-8. PubMed ID: 12359767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: the CDKN2A (p16(INK4a) and p14(ARF) ) and p53 genes are major targets for inactivation.
    Smeds J; Berggren P; Ma X; Xu Z; Hemminki K; Kumar R
    Carcinogenesis; 2002 Apr; 23(4):645-55. PubMed ID: 11960918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice.
    Krimpenfort P; Quon KC; Mooi WJ; Loonstra A; Berns A
    Nature; 2001 Sep; 413(6851):83-6. PubMed ID: 11544530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p16(Ink4a) interferes with Abelson virus transformation by enhancing apoptosis.
    Sachs Z; Sharpless NE; DePinho RA; Rosenberg N
    J Virol; 2004 Apr; 78(7):3304-11. PubMed ID: 15016851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficiency alleles of the Pctr1 modifier locus for plasmacytoma susceptibility.
    Zhang SL; DuBois W; Ramsay ES; Bliskovski V; Morse HC; Taddesse-Heath L; Vass WC; DePinho RA; Mock BA
    Mol Cell Biol; 2001 Jan; 21(1):310-8. PubMed ID: 11113205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic alterations of INK4alpha/ARF locus and p53 in human hepatocellular carcinoma.
    Peng CY; Chen TC; Hung SP; Chen MF; Yeh CT; Tsai SL; Chu CM; Liaw YF
    Anticancer Res; 2002; 22(2B):1265-71. PubMed ID: 12168936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between alterations of p16(INK4a) and p14(ARF) genes of CDKN2A locus and gastric carcinogenesis.
    Tang S; Luo H; Yu J; Yang D; Shu J
    Chin Med J (Engl); 2003 Jul; 116(7):1083-7. PubMed ID: 12890389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Losses of both products of the Cdkn2a/Arf locus contribute to asbestos-induced mesothelioma development and cooperate to accelerate tumorigenesis.
    Altomare DA; Menges CW; Xu J; Pei J; Zhang L; Tadevosyan A; Neumann-Domer E; Liu Z; Carbone M; Chudoba I; Klein-Szanto AJ; Testa JR
    PLoS One; 2011 Apr; 6(4):e18828. PubMed ID: 21526190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 and p16
    Azzopardi S; Pang S; Klimstra DS; Du YN
    Neoplasia; 2016 Oct; 18(10):610-617. PubMed ID: 27664376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
    Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
    Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detecting homozygous deletions in the CDKN2A(p16(INK4a))/ARF(p14(ARF)) gene in urinary bladder cancer using real-time quantitative PCR.
    Berggren P; Kumar R; Sakano S; Hemminki L; Wada T; Steineck G; Adolfsson J; Larsson P; Norming U; Wijkström H; Hemminki K
    Clin Cancer Res; 2003 Jan; 9(1):235-42. PubMed ID: 12538475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of the INK4a-ARF gene locus in pleomorphic adenoma of the parotid gland.
    Weber A; Langhanki L; Schütz A; Wittekind C; Bootz F; Tannapfel A
    J Pathol; 2002 Nov; 198(3):326-34. PubMed ID: 12375265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer.
    Kanao H; Enomoto T; Ueda Y; Fujita M; Nakashima R; Ueno Y; Miyatake T; Yoshizaki T; Buzard GS; Kimura T; Yoshino K; Murata Y
    Cancer Lett; 2004 Sep; 213(1):31-7. PubMed ID: 15312681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.